Alkermes (FRA:8AK) Cyclically Adjusted Book per Share: €6.54 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:8AK Alkermes PLC FRA:8AK
72 GF Score
Price €44.94
GF Value €27.42
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Alkermes Cyclically Adjusted Book per Share?

Alkermes FRA:8AK +0.38% 72 Cyclically Adjusted Book per Share is €6.54 as of Mar. 2026. GuruFocus rates FRA:8AK with a GF Score™ of 72/100 and a GF Value™ of €27.42 (Significantly Overvalued). The stock has 8 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Alkermes's adjusted book value per share for the three months ended in Mar. 2026 was €9.102. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.54 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Alkermes's average Cyclically Adjusted Book Growth Rate was 2.70% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 0.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 2.80% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Alkermes was 29.10% per year. The lowest was -4.50% per year. And the median was 4.30% per year.

As of today (2026-07-17), Alkermes's current stock price is €44.94. Alkermes's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €6.54. Alkermes's Cyclically Adjusted PB Ratio of today is 6.87.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Alkermes was 9.33. The lowest was 1.65. And the median was 3.25.


Alkermes  (FRA:8AK) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Alkermes's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=44.94/6.54
=6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Alkermes was 9.33. The lowest was 1.65. And the median was 3.25.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Alkermes Cyclically Adjusted Book per Share Related Terms


Alkermes Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Alkermes's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkermes Cyclically Adjusted Book per Share Chart

Alkermes Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.32 8.02 7.92 8.37 7.33

Alkermes Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.93 7.36 7.02 7.33 6.54

FRA:8AK vs HIMS, LNTH, LQDA: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Alkermes's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Alkermes Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alkermes's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Alkermes's Cyclically Adjusted PB Ratio falls into.


FRA:8AK
72GF Score
Alkermes PLC FRA:8AK
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkermes Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Alkermes's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=9.102/127.8300*127.8300
=9.102

Current CPI (Mar. 2026) = 127.8300.

Alkermes Quarterly Data

Book Value per Share CPI Adj_Book
201606 7.305 101.072 9.239
201609 7.100 100.274 9.051
201612 7.522 99.676 9.647
201703 7.429 100.374 9.461
201706 6.963 100.673 8.841
201709 6.479 100.474 8.243
201712 6.599 100.075 8.429
201803 6.048 100.573 7.687
201806 6.384 101.072 8.074
201809 6.347 101.371 8.004
201812 6.610 100.773 8.385
201903 6.217 101.670 7.817
201906 6.147 102.168 7.691
201909 6.158 102.268 7.697
201912 6.192 102.068 7.755
202003 6.063 102.367 7.571
202006 5.929 101.769 7.447
202009 5.786 101.072 7.318
202012 5.511 101.072 6.970
202103 5.512 102.367 6.883
202106 5.650 103.364 6.987
202109 5.763 104.859 7.025
202112 6.080 106.653 7.287
202203 5.983 109.245 7.001
202206 6.234 112.779 7.066
202209 6.411 113.504 7.220
202212 5.994 115.436 6.638
202303 5.656 117.609 6.148
202306 7.098 119.662 7.583
202309 7.619 120.749 8.066
202312 6.605 120.749 6.992
202403 6.823 120.990 7.209
202406 7.191 122.318 7.515
202409 7.196 121.594 7.565
202412 8.627 122.439 9.007
202503 8.482 123.405 8.786
202506 8.534 124.492 8.763
202509 8.945 124.810 9.161
202512 9.382 125.770 9.536
202603 9.102 127.830 9.102

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €6.54 mean?
Alkermes (FRA:8AK) has a Cyclically Adjusted Book per Share of €6.54 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alkermes and its competitors.
Is Alkermes' Cyclically Adjusted Book per Share too high?
Alkermes' current Cyclically Adjusted Book per Share is €6.54. Overall, Alkermes has a GF Score™ of 72/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alkermes' Cyclically Adjusted Book per Share compare to HIMS and LNTH?
Alkermes' Cyclically Adjusted Book per Share of €6.54 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Alkermes and its competitors. Alkermes's current Cyclically Adjusted Book per Share is €6.54. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkermes stock overvalued right now?
Based on GuruFocus' analysis, Alkermes (FRA:8AK) is currently considered Significantly Overvalued. The stock's GF Value™ is €27.42, compared to a current price of €44.94 — trading 63.9% above its estimated fair value. The current Cyclically Adjusted Book per Share is €6.54. Alkermes' overall GF Score™ is 72/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Alkermes (FRA:8AK), the current Cyclically Adjusted Book per Share is €6.54 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkermes (FRA:8AK) Overvalued in 2026?

Based on GuruFocus' analysis, Alkermes stock appears to be overvalued. The current stock price of €44.94 is trading 63.9% above its estimated GF Value™ of €27.42. GuruFocus considers Alkermes to be Significantly Overvalued.

Key valuation signals for FRA:8AK:

  • Cyclically Adjusted Book per Share: €6.54
  • GF Value™: €27.42 vs. price of €44.94 (63.9% above fair value)
  • GF Score™: 72/100 with 8 warning signs

No single metric tells the full story. See the FRA:8AK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Alkermes Business Description

Other Exchanges ALKS:USA
Address 1 Burlington Road, Connaught House, Dublin, IRL, D04 C5Y6
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
72GF Score

Get the complete analysis for FRA:8AK

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€44.94
Price
€27.42
GF Value